210 related articles for article (PubMed ID: 34641958)
21. Characterization of the conditioned medium from amniotic membrane cells: prostaglandins as key effectors of its immunomodulatory activity.
Rossi D; Pianta S; Magatti M; Sedlmayr P; Parolini O
PLoS One; 2012; 7(10):e46956. PubMed ID: 23071674
[TBL] [Abstract][Full Text] [Related]
22. 26 Development of human amniotic membrane products for regenerative medicine applications.
Barrera V; Rathbone S; Joseph A; Rooney P
BMJ Open Ophthalmol; 2022 Nov; 7(Suppl 2):A11. PubMed ID: 37282673
[TBL] [Abstract][Full Text] [Related]
23. Towards the Standardization of Mesenchymal Stem Cell Secretome-Derived Product Manufacturing for Tissue Regeneration.
Chouaib B; Haack-Sørensen M; Chaubron F; Cuisinier F; Collart-Dutilleul PY
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628774
[TBL] [Abstract][Full Text] [Related]
24. Secretome of Human Fetal Mesenchymal Stem Cell Ameliorates Replicative Senescen.
Wang B; Lee WY; Huang B; Zhang JF; Wu T; Jiang X; Wang CC; Li G
Stem Cells Dev; 2016 Nov; 25(22):1755-1766. PubMed ID: 27539404
[TBL] [Abstract][Full Text] [Related]
25. Effects of Stromal Cell Conditioned Medium and Antipurinergic Treatment on Macrophage Phenotype.
Arabiyat AS; Yeisley DJ; Güiza-Argüello VR; Qureshi F; Culibrk RA; Hahn J; Hahn MS
Tissue Eng Part C Methods; 2022 Dec; 28(12):656-671. PubMed ID: 36329666
[TBL] [Abstract][Full Text] [Related]
26. Bone Marrow-Mesenchymal Stromal Cell Secretome as Conditioned Medium Relieves Experimental Skeletal Muscle Damage Induced by Ex Vivo Eccentric Contraction.
Squecco R; Tani A; Chellini F; Garella R; Idrizaj E; Rosa I; Zecchi-Orlandini S; Manetti M; Sassoli C
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807453
[TBL] [Abstract][Full Text] [Related]
27. Mesenchymal Stromal Cell Secretome: Influencing Therapeutic Potential by Cellular Pre-conditioning.
Ferreira JR; Teixeira GQ; Santos SG; Barbosa MA; Almeida-Porada G; Gonçalves RM
Front Immunol; 2018; 9():2837. PubMed ID: 30564236
[TBL] [Abstract][Full Text] [Related]
28. Hydrogel Culture Surface Stiffness Modulates Mesenchymal Stromal Cell Secretome and Alters Senescence.
Ogle ME; Doron G; Levy MJ; Temenoff JS
Tissue Eng Part A; 2020 Dec; 26(23-24):1259-1271. PubMed ID: 32628570
[TBL] [Abstract][Full Text] [Related]
29. Human amniotic membrane as an alternative source of stem cells for regenerative medicine.
Díaz-Prado S; Muiños-López E; Hermida-Gómez T; Cicione C; Rendal-Vázquez ME; Fuentes-Boquete I; de Toro FJ; Blanco FJ
Differentiation; 2011 Mar; 81(3):162-71. PubMed ID: 21339039
[TBL] [Abstract][Full Text] [Related]
30. miR-21 Contributes to Human Amniotic Membrane-Derived Mesenchymal Stem Cell Growth and Human Amniotic Membrane-Derived Mesenchymal Stem Cell-Induced Immunoregulation.
Zhang Y; Zhang W; Wang H; Yang B
Genet Test Mol Biomarkers; 2018 Dec; 22(12):665-673. PubMed ID: 30481073
[TBL] [Abstract][Full Text] [Related]
31. Comparison of Immunosuppressive and Angiogenic Properties of Human Amnion-Derived Mesenchymal Stem Cells between 2D and 3D Culture Systems.
Miceli V; Pampalone M; Vella S; Carreca AP; Amico G; Conaldi PG
Stem Cells Int; 2019; 2019():7486279. PubMed ID: 30911299
[TBL] [Abstract][Full Text] [Related]
32. Inflammatory priming enhances mesenchymal stromal cell secretome potential as a clinical product for regenerative medicine approaches through secreted factors and EV-miRNAs: the example of joint disease.
Ragni E; Perucca Orfei C; De Luca P; Mondadori C; Viganò M; Colombini A; de Girolamo L
Stem Cell Res Ther; 2020 Apr; 11(1):165. PubMed ID: 32345351
[TBL] [Abstract][Full Text] [Related]
33. [Comparison of Biological Characteristics and Immunosuppressive Activity between Human Amniotic Mesenchymal Stem Cells and Human Bone Marrow Mesenchymal Stem Cells].
Hong JQ; Gao Y; Song J; Zhuo WB; Sun HT; Ping BH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):858-64. PubMed ID: 27342523
[TBL] [Abstract][Full Text] [Related]
34. Human amniotic mesenchymal stem cell-derived induced pluripotent stem cells may generate a universal source of cardiac cells.
Ge X; Wang IN; Toma I; Sebastiano V; Liu J; Butte MJ; Reijo Pera RA; Yang PC
Stem Cells Dev; 2012 Oct; 21(15):2798-808. PubMed ID: 22530853
[TBL] [Abstract][Full Text] [Related]
35. New perspectives for prostate cancer treatment: in vitro inhibition of LNCaP and PC3 cell proliferation by amnion-derived mesenchymal stromal cells conditioned media.
Rolfo A; Giuffrida D; Giuffrida MC; Todros T; Calogero AE
Aging Male; 2014 Jun; 17(2):94-101. PubMed ID: 24597941
[TBL] [Abstract][Full Text] [Related]
36. Human Amniotic Mesenchymal Stem Cell Sheets Encapsulating Cartilage Particles Facilitate Repair of Rabbit Osteochondral Defects.
You Q; Liu Z; Zhang J; Shen M; Li Y; Jin Y; Liu Y
Am J Sports Med; 2020 Mar; 48(3):599-611. PubMed ID: 31940211
[TBL] [Abstract][Full Text] [Related]
37. Dental Pulp Stem Cell-Derived Conditioned Medium: An Attractive Alternative for Regenerative Therapy.
Kichenbrand C; Velot E; Menu P; Moby V
Tissue Eng Part B Rev; 2019 Feb; 25(1):78-88. PubMed ID: 30156475
[TBL] [Abstract][Full Text] [Related]
38. Growth factors and their receptors derived from human amniotic cells in vitro.
Grzywocz Z; Pius-Sadowska E; Klos P; Gryzik M; Wasilewska D; Aleksandrowicz B; Dworczynska M; Sabalinska S; Hoser G; Machalinski B; Kawiak J
Folia Histochem Cytobiol; 2014; 52(3):163-70. PubMed ID: 25308731
[TBL] [Abstract][Full Text] [Related]
39. Strategies for immortalisation of amnion-derived mesenchymal and epithelial cells.
Ansari A; Denton KM; Lim R
Cell Biol Int; 2022 Dec; 46(12):1999-2008. PubMed ID: 35998259
[TBL] [Abstract][Full Text] [Related]
40. Transplantation of human amnion prevents recurring adhesions and ameliorates fibrosis in a rat model of sciatic nerve scarring.
Lemke A; Ferguson J; Gross K; Penzenstadler C; Bradl M; Mayer RL; Gerner C; Redl H; Wolbank S
Acta Biomater; 2018 Jan; 66():335-349. PubMed ID: 29191510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
